NCT05244395View on ClinicalTrials.gov

Development of a New Instrument to Evaluate Gait Characteristics of Individuals With Duchenne Muscular Dystrophy

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 10, 2020

Primary Completion Date

November 30, 2021

Study Completion Date

February 10, 2022

Conditions
Duchenne Muscular DystrophyGait Disorders in ChildrenGait Disorders, Neurologic
Interventions
OTHER

Duchenne Muscular Dystrophy Gait Assessment Scale

a special gait assessment scale for Duchenne Muscular Dystrophy patients

Trial Locations (1)

06100

Hacettepe University, Ankara

All Listed Sponsors
lead

Hacettepe University

OTHER

NCT05244395 - Development of a New Instrument to Evaluate Gait Characteristics of Individuals With Duchenne Muscular Dystrophy | Biotech Hunter | Biotech Hunter